DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Gopal Snacks Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·2 Nov 2026, 7:10 am

Gopal Snacks

Gopal Snacks Limited has informed stock exchanges that it is holding an institutional investor meet or conference call. This event is scheduled to take place in the coming days. The company is using this platform to engage directly with analysts and institutional investors to discuss its business performance and future outlook.

For investors, such meetings are significant as they provide a rare opportunity to hear management's unscripted commentary on market trends, operational strategies, and financial targets. This transparency helps retail investors gauge the company's confidence and clarity regarding its growth trajectory.

Investors should watch for updates on the company's guidance regarding volume growth, pricing power, and margin expansion. Any comments on raw material costs or new product launches will also be key areas of focus to assess the stock's short-term and medium-term potential.